| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |